# Vitamin C from Porphyra umbilicalis (Red Seaweed)

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/vitamin-c-from-porphyra-umbilicalis-red-seaweed
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-04-05
**Evidence Score:** 1 / 10
**Category:** Marine-Derived
**Also Known As:** Porphyra umbilicalis, Umbilical laver, Atlantic nori, Rock laver, Pyropia umbilicalis

## Overview

Porphyra umbilicalis delivers ascorbic acid (vitamin C) at approximately 1.05 ± 0.27 mg/g fresh weight alongside a matrix of polyphenols, mycosporine-like amino acids, and sulfated polysaccharides that collectively act as reductants, free-radical scavengers, and collagen biosynthesis cofactors. In an animal model using HPV16-transgenic mice, dietary supplementation with P. umbilicalis whole extract significantly reduced the incidence of pre-malignant dysplastic lesions and completely eliminated them in chest skin, though human clinical trial data for isolated vitamin C from this source remain absent.

## Health Benefits

- **Antioxidant Protection**: Ascorbic acid in P. umbilicalis donates electrons to neutralize [reactive oxygen species](/ingredients/condition/antioxidant) (ROS), while co-occurring phenolics and terpenoids provide complementary radical-scavenging activity, creating a multi-pathway antioxidant defense.
- **Collagen and Connective Tissue Support**: Vitamin C serves as an obligate cofactor for prolyl and lysyl hydroxylases, enzymes essential for the hydroxylation of proline and lysine residues during collagen triple-helix stabilization, supporting [skin elasticity](/ingredients/condition/skin-health) and wound repair.
- **UV Photoprotection**: Mycosporine-like amino acids (MAAs) present in the seaweed absorb UV radiation in the 310–360 nm range, complementing vitamin C's role in quenching photo-induced free radicals and reducing oxidative DNA damage in skin cells.
- **[Anti-inflammatory](/ingredients/condition/inflammation) Activity**: Phenolic compounds and sulfated polysaccharides in P. umbilicalis inhibit pro-inflammatory mediators, with vitamin C additionally suppressing NF-κB signaling pathways that drive cytokine-mediated inflammation.
- **Iron Absorption Enhancement**: Ascorbic acid reduces ferric iron (Fe³⁺) to the more bioavailable ferrous form (Fe²⁺) in the gastrointestinal tract, improving non-heme iron uptake from plant-based dietary sources consumed alongside the seaweed.
- **Carnitine Biosynthesis Support**: Vitamin C acts as a reductant for two hydroxylation steps in the enzymatic synthesis of L-carnitine from lysine and methionine, supporting mitochondrial fatty acid transport and [energy metabolism](/ingredients/condition/energy).
- **Potential Chemopreventive Activity**: Whole-extract supplementation in HPV16-transgenic mice suppressed pre-malignant dysplastic lesion formation, an effect attributed to the combined antioxidant, anti-inflammatory, and immune-modulatory compounds in the seaweed matrix, though isolated vitamin C contribution has not been quantified separately.

## Mechanism of Action

Vitamin C (ascorbic acid) functions primarily as a two-electron reductant, donating electrons sequentially to convert ascorbate radical (semidehydroascorbate) and then to dehydroascorbic acid, thereby quenching superoxide, hydroxyl radicals, and singlet oxygen in both aqueous cellular compartments and extracellular fluids. At the enzymatic level, ascorbic acid maintains the ferrous (Fe²⁺) and cuprous (Cu⁺) oxidation states of metal-dependent dioxygenases, including collagen prolyl-4-hydroxylase and lysyl hydroxylase, as well as the enzymes required for carnitine and catecholamine biosynthesis. Complementary bioactives in P. umbilicalis—specifically sulfated polysaccharides and phlorotannin-class phenolics—modulate toll-like receptor signaling and inhibit [lipid peroxidation](/ingredients/condition/antioxidant) via suppression of 5-lipoxygenase and cyclooxygenase pathways, amplifying the antioxidant and [anti-inflammatory](/ingredients/condition/inflammation) effects beyond ascorbic acid alone. Mycosporine-like amino acids in the seaweed matrix absorb UV photons directly, reducing photochemical generation of ROS that would otherwise deplete intracellular ascorbate pools.

## Clinical Summary

To date, no human clinical trials have been conducted examining vitamin C from P. umbilicalis as an isolated ingredient, making it impossible to draw evidence-based conclusions about efficacy, effective dose, or comparative bioavailability in human populations. The sole interventional study identified used a murine HPV16-transgenic model, which demonstrated reduced dysplastic lesion incidence following whole-seaweed dietary supplementation; while promising, rodent chemoprevention models have historically shown limited translational fidelity to human outcomes. Nutritional epidemiological data on Porphyra species consumption in coastal European and East Asian populations suggest general safety and tolerability as a food, but these population-level observations do not constitute clinical evidence for therapeutic vitamin C delivery. The overall clinical evidence for this specific ingredient-source combination must be classified as preliminary, and clinicians should contextualize any potential benefit within the well-established pharmacology of ascorbic acid from other, more thoroughly characterized sources.

## Nutritional Profile

Per gram of fresh weight, P. umbilicalis provides approximately 1.05 ± 0.27 mg vitamin C (ascorbic acid), making it a modest but measurable dietary source. The species is notably protein-rich for a seaweed, with protein comprising up to 35–47% of dry weight, including all essential amino acids; it also contains vitamins A, B12, B1, B2, and E, iodine, iron, calcium, and magnesium. Bioactive phytochemicals include sulfated polysaccharides (primarily porphyran), mycosporine-like amino acids (palythine, shinorine), phenolic compounds, and carotenoids including β-carotene and zeaxanthin. Bioavailability of ascorbic acid from the seaweed matrix has not been independently measured; polysaccharide-bound matrices can theoretically modulate gastrointestinal transit and absorption kinetics, but this has not been studied for this species. Dietary fiber content contributes to the food's functional properties and may influence the rate of nutrient release in the gastrointestinal tract.

## Dosage & Preparation

- **Dried Whole Seaweed (Food Form)**: An 8 g serving of dried P. umbilicalis provides approximately 9 mg of vitamin C; no standardized supplemental dose has been established from clinical trials for this source.
- **Drying Protocol (Research Standard)**: Harvested seaweed is dried at 25°C in a controlled-temperature chamber for 24 hours to reach 10–12% residual humidity, preserving heat-labile vitamin C and other bioactives.
- **Powdered Extract (Cosmetic/Nutraceutical)**: Commercial skincare and nutraceutical preparations use P. umbilicalis extract standardized to polysaccharide or total phenolic content rather than ascorbic acid percentage; vitamin C content in such extracts is variable and not typically guaranteed.
- **Fresh Consumption**: Fresh wild-harvested seaweed consumed immediately post-harvest retains the highest ascorbic acid concentration (~1.05 mg/g); prolonged storage, heat processing, or exposure to oxidative conditions significantly degrades ascorbate content.
- **Timing Note**: As with all dietary vitamin C sources, consumption with iron-containing meals is recommended to maximize non-heme iron bioavailability enhancement; no specific timing optimization data exist for this species.

## Safety & Drug Interactions

P. umbilicalis consumed as a food has an extensive history of safe human consumption across European coastal cultures, and the mouse supplementation study reported normal toxicological parameters in blood biochemistry analyses; however, formal human safety data for concentrated P. umbilicalis extracts or standardized vitamin C preparations derived from this species are absent from the current literature. At typical dietary levels (8–20 g dried seaweed), vitamin C intake from this source falls well below the tolerable upper intake level of 2,000 mg/day established for ascorbic acid in adults, making GI distress or oxalate-related adverse effects from vitamin C alone unlikely at food doses. The seaweed's naturally high iodine content may be a relevant concern for individuals with [thyroid](/ingredients/condition/hormonal) disorders (Hashimoto's thyroiditis, Graves' disease) or those taking antithyroid medications, levothyroxine, or lithium, and intake should be discussed with a healthcare provider in these populations. Individuals taking anticoagulants (warfarin) should be aware that high seaweed intake may influence vitamin K intake and coagulation parameters; pregnant and lactating individuals should limit intake due to the potential for excess iodine exposure, though moderate dietary consumption is generally considered safe.

## Scientific Research

The evidence base for vitamin C specifically isolated from P. umbilicalis is extremely limited; most published research examines the whole seaweed extract or the species' broader nutritional composition rather than its ascorbic acid fraction in isolation. One preclinical animal study demonstrated that dietary supplementation with dried P. umbilicalis in HPV16-transgenic mice produced a statistically significant reduction in pre-malignant dysplastic skin lesions, with complete elimination observed in chest skin tissue; however, the study did not isolate vitamin C as the responsible agent and noted that further research is needed before functional food status can be established. Analytical chemistry studies from Galician coastal samples have reliably quantified vitamin C at approximately 1.05 ± 0.27 mg/g fresh weight, providing a benchmark concentration, but no human pharmacokinetic or bioavailability trials comparing P. umbilicalis-derived ascorbate with synthetic ascorbic acid have been published. No randomized controlled trials, systematic reviews, or meta-analyses specifically addressing supplemental vitamin C from P. umbilicalis are currently available in the peer-reviewed literature.

## Historical & Cultural Context

Porphyra umbilicalis and closely related Porphyra species have been harvested and consumed along Atlantic European coastlines for centuries, with documented use in Wales (as 'laver bread,' prepared by boiling and mixing with oats), Ireland, Scotland, and coastal Portugal and Spain, where the seaweed was incorporated into local diets as a nutritious, minerally dense food. In East Asia, related species within the Porphyra/Pyropia genus have been cultivated and consumed as 'nori' for over 1,400 years in Japan and China, where it was listed in ancient agricultural texts as both a food and a therapeutic agent for goiter associated with iodine deficiency. Atlantic coastal communities historically valued the seaweed for its sustaining protein and vitamin content, particularly during winter months when other fresh vegetables were scarce, though no formal ethnopharmacological record specifically attributes medicinal use to its vitamin C content. The species was formally described in modern taxonomy by Roth (1797) and has since attracted scientific interest as a model organism in seaweed genomics, with its complete nuclear genome sequenced in 2018, facilitating contemporary nutraceutical and cosmeceutical research.

## Synergistic Combinations

Vitamin C from P. umbilicalis exhibits well-established synergy with non-heme dietary iron sources (legumes, grains, leafy vegetables) by reducing Fe³⁺ to the more bioavailable Fe²⁺ form in the gut lumen, a combination particularly relevant for plant-based diets where iron bioavailability is otherwise limited. Co-consumption with vitamin E (tocopherol) creates a regenerative antioxidant cycle in which ascorbic acid reduces the tocopheroxyl radical back to active tocopherol, restoring lipid-phase antioxidant capacity after membrane [lipid peroxidation](/ingredients/condition/antioxidant) events. The intact P. umbilicalis matrix—where vitamin C co-occurs with mycosporine-like amino acids, porphyran polysaccharides, and phenolic compounds—may offer superior [photoprotect](/ingredients/condition/skin-health)ive and anti-inflammatory synergy compared to isolated ascorbic acid supplementation, as these compounds act on complementary oxidative and [inflammatory pathway](/ingredients/condition/inflammation)s simultaneously.

## Frequently Asked Questions

### How much vitamin C does Porphyra umbilicalis contain?

Fresh P. umbilicalis contains approximately 1.05 ± 0.27 mg of vitamin C per gram of fresh weight, as measured in wild samples from Galicia, Spain. An 8-gram serving of dried seaweed provides roughly 9 mg of vitamin C, which represents a modest contribution toward the adult recommended daily allowance of 65–90 mg but is far below therapeutic supplemental doses.

### Is Porphyra umbilicalis a good source of vitamin C compared to other foods?

P. umbilicalis is a moderate dietary source of vitamin C relative to other seaweeds, but it does not rival high-potency plant sources such as acerola cherry (~1,600 mg/100 g), rosehip (~400 mg/100 g), or bell pepper (~80–130 mg/100 g). Its nutritional value lies in combining modest vitamin C with a unique matrix of complementary bioactives—including mycosporine-like amino acids, sulfated polysaccharides, and complete protein—that are absent from terrestrial vitamin C sources.

### What are the antioxidant benefits of Porphyra umbilicalis?

P. umbilicalis delivers antioxidant activity through multiple chemical classes: ascorbic acid scavenges aqueous-phase reactive oxygen species, phenolic compounds and terpenoids inhibit lipid peroxidation, and mycosporine-like amino acids absorb UV radiation to prevent photochemical ROS generation. In an HPV16-transgenic mouse model, whole-seaweed dietary supplementation significantly reduced pre-malignant dysplastic skin lesions, including complete elimination in chest skin tissue, though the study examined the whole extract rather than isolated vitamin C.

### Are there any safety concerns with consuming Porphyra umbilicalis?

P. umbilicalis has a well-established history of safe dietary consumption in coastal European communities; the primary safety consideration is its naturally high iodine content, which may be problematic for individuals with thyroid disorders or those taking thyroid medications, anticoagulants, or lithium. At typical food intake levels, vitamin C from this seaweed remains far below the 2,000 mg/day tolerable upper intake level, making ascorbate-specific adverse effects unlikely; however, concentrated commercial extracts have not been formally evaluated for safety in human trials.

### Can Porphyra umbilicalis vitamin C support collagen production?

Yes, the ascorbic acid present in P. umbilicalis functions as a required cofactor for prolyl-4-hydroxylase and lysyl hydroxylase, the enzymes that hydroxylate proline and lysine residues to stabilize the collagen triple-helix structure during biosynthesis. While this mechanism is well-established for ascorbic acid broadly, no human clinical trial has specifically tested collagen synthesis outcomes using P. umbilicalis-derived vitamin C, so the magnitude of this effect from dietary seaweed consumption at realistic serving sizes has not been quantified.

### How does the vitamin C in Porphyra umbilicalis differ from synthetic ascorbic acid supplements?

Porphyra umbilicalis provides vitamin C alongside naturally occurring phenolic compounds and terpenoids that work synergistically to enhance antioxidant effectiveness, whereas synthetic ascorbic acid is an isolated compound without these co-factors. The seaweed matrix may improve bioavailability and provide broader protective effects against oxidative stress through multiple free-radical scavenging pathways. This whole-food approach contrasts with single-nutrient supplementation, though both forms supply the active ascorbic acid molecule needed for collagen synthesis.

### Does Porphyra umbilicalis vitamin C have better absorption compared to citrus-derived vitamin C?

Porphyra umbilicalis contains naturally chelated minerals and polysaccharides that may enhance vitamin C absorption in the digestive tract, potentially offering bioavailability advantages over isolated citrus extracts. The seaweed's fiber matrix can slow gastric transit, allowing for more sustained and efficient absorption in the small intestine. However, direct comparative absorption studies between these specific sources are limited, and individual factors like gut health significantly influence overall bioavailability regardless of source.

### Is Porphyra umbilicalis safe for people taking blood thinners or anticoagulant medications?

Porphyra umbilicalis is generally recognized as safe for most populations, but individuals taking anticoagulants should consult their healthcare provider, as seaweed can contain vitamin K which may interact with blood thinners like warfarin. The vitamin C content itself does not typically interact with anticoagulants, but the whole seaweed extract warrants medical review for personalized risk assessment. Consistent intake rather than occasional use is the primary concern, as sudden changes in vitamin K consumption can affect medication efficacy.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*